In the BL cohort, our newly generated score (based on IL-10, MDC, MIF, and eotaxin-3 cytokines) showed a significant role as independent prognostic factor for PFS (HR = 4.07; 95% CI: 1.48–11.5; p = 0.006). The gene discussed is MIF; the disease is Burkitt lymphoma.